Suppr超能文献

人类免疫缺陷病毒缓解的挑战与前景。

Challenges and Promise of Human Immunodeficiency Virus Remission.

机构信息

Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

出版信息

J Infect Dis. 2021 Feb 15;223(12 Suppl 2):4-12. doi: 10.1093/infdis/jiaa568.

Abstract

Antiretroviral therapy effectively controls human immunodeficiency virus (HIV) replication but it is unable to fully eradicate the HIV reservoir and treatment must be life-long. Progress toward a strategy for HIV remission will require overcoming key hurdles to fill gaps in our understanding of HIV persistence, but the identification of individuals who have attained sterilizing or functional HIV cure show that such a goal is achievable. In this review, we first outline challenges in targeting the HIV reservoir, including difficulties identifying HIV-infected cells, ongoing work elucidating the complex intracellular environment that contribute to HIV latency, and barriers to reactivating and clearing the HIV reservoir. We then review reported cases of HIV sterilizing cure and explore natural models of HIV remission and the promise that such HIV spontaneous and posttreatment controllers may hold in our search for a broadly-applicable strategy for the millions of patients living with HIV.

摘要

抗逆转录病毒疗法可有效控制人类免疫缺陷病毒(HIV)复制,但无法完全清除 HIV 储存库,因此治疗必须是终身的。要实现 HIV 缓解的策略,就需要克服关键障碍,填补我们对 HIV 持续存在的理解空白,但鉴定出已达到根治或功能性 HIV 治愈的个体表明,这一目标是可以实现的。在这篇综述中,我们首先概述了针对 HIV 储存库的靶向治疗所面临的挑战,包括鉴定 HIV 感染细胞的困难、阐明导致 HIV 潜伏期的复杂细胞内环境的持续工作,以及重新激活和清除 HIV 储存库的障碍。然后,我们回顾了 HIV 根治性治愈的报道病例,并探讨了 HIV 自然缓解的模型,以及此类 HIV 自发性和治疗后控制者在我们寻找适用于数百万 HIV 感染者的广泛应用策略方面的潜力。

相似文献

3
Therapeutics for HIV-1 reactivation from latency.HIV-1 潜伏激活的治疗方法。
Curr Opin Virol. 2013 Aug;3(4):394-401. doi: 10.1016/j.coviro.2013.06.001. Epub 2013 Jun 28.
7
A broad drug arsenal to attack a strenuous latent HIV reservoir.用广泛的药物武器来攻击顽固的潜伏 HIV 储库。
Curr Opin Virol. 2019 Oct;38:37-53. doi: 10.1016/j.coviro.2019.06.001. Epub 2019 Jul 16.
8
Progress and challenges in the use of latent HIV-1 reactivating agents.潜伏性HIV-1激活剂使用中的进展与挑战
Acta Pharmacol Sin. 2015 Aug;36(8):908-16. doi: 10.1038/aps.2015.22. Epub 2015 Jun 1.

引用本文的文献

1
Advanced Therapies for Human Immunodeficiency Virus.人类免疫缺陷病毒的先进治疗方法。
Med Sci (Basel). 2024 Jul 18;12(3):33. doi: 10.3390/medsci12030033.
2
HIV post-treatment controllers have distinct immunological and virological features.HIV 治疗后控制者具有独特的免疫学和病毒学特征。
Proc Natl Acad Sci U S A. 2023 Mar 14;120(11):e2218960120. doi: 10.1073/pnas.2218960120. Epub 2023 Mar 6.
3
The Search for an HIV Cure: Where Do We Go From Here?HIV 治愈方法的探索:我们的路在何方?
J Infect Dis. 2021 Feb 15;223(12 Suppl 2):1-3. doi: 10.1093/infdis/jiaa738.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验